Radiation Oncology

Latest News

Despite Treatment Advances, Oral Mucositis Continues to Plague Patients With Head and Neck Cancer
Despite Treatment Advances, Oral Mucositis Continues to Plague Patients With Head and Neck Cancer

November 21st 2023

Data from a single-institution study showed that 98.6% of their patients with head and neck cancer experienced oral mucositis.

SABR Yields ’Exceptional‘ Outcomes in Older Patients With Inoperable Renal Cell Carcinoma
SABR Yields ’Exceptional‘ Outcomes in Older Patients With Inoperable Renal Cell Carcinoma

October 13th 2023

breast cancer
Long-Term Safety and Efficacy Is Reported With Partial-Breast Radiotherapy in Early-Stage Breast Cancer

October 6th 2023

gynecologic oncology
Vaginal Dilation and Sexual Activity Linked to Lower Sexual Dysfunction Following Cervical Cancer Treatment

October 6th 2023

radiotherapy scanning
New Approach to Palliative Radiation Plans Reduces the Amount of Time Patients Spend in Treatment Centers

October 5th 2023

Video Interviews
Latest CME Events & Activities

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

Register Now!

2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference

View More

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2023 MJH Life Sciences

All rights reserved.